Evaluation of the (177m)Lu-concentration in in-house produced (177)Lu-radiopharmaceuticals and commercially available Lutathera(®)

BACKGROUND: (177)Lu-radiopharmaceuticals can contain the metastable impurity [(177m)Lu]lutetium with a physical half-life of 160.4 days, in varying concentrations depending on the route of production of the radionuclidic precursor [(177)Lu]lutetium. Due to the long half-life of [(177m)Lu]lutetium, d...

Descripción completa

Detalles Bibliográficos
Autores principales: Balzer, Matthias, Spiecker, Fleur, Bluemel, Stephanie, Amthauer, Holger, Brenner, Winfried, Spreckelmeyer, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628054/
https://www.ncbi.nlm.nih.gov/pubmed/37930495
http://dx.doi.org/10.1186/s41181-023-00222-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628054/
https://www.ncbi.nlm.nih.gov/pubmed/37930495
http://dx.doi.org/10.1186/s41181-023-00222-2

Ejemplares similares